Chiesi Farmaceutici S.p.A.

Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Neurology · Renal & urogenital · Respiratory · Women's health

Chiesi Farmaceutici S.p.A. is a clinical trial sponsor. It has 21 active clinical trials with 29,422 planned participants, across 12 therapeutic areas. Since 2021 it has completed 77 trials and stopped 14 early.

Trial track record · since 2021

21Active trials29,422 planned participants
77Completed29 with results posted
14Stopped early15% of finished trials

Pipeline · 21 active trials

StageTrialStatus

Questions about Chiesi Farmaceutici S.p.A

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-26.

Approve Suite is not affiliated with Chiesi Farmaceutici S.p.A..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.